Cargando…
Focusing on Risk Communication About Medicines: Why Now?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585946/ https://www.ncbi.nlm.nih.gov/pubmed/23061774 http://dx.doi.org/10.1007/BF03261984 |
| _version_ | 1782261242155499520 |
|---|---|
| author | Bahri, Priya Harrison-Woolrych, Mira |
| author_facet | Bahri, Priya Harrison-Woolrych, Mira |
| author_sort | Bahri, Priya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3585946 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35859462013-03-07 Focusing on Risk Communication About Medicines: Why Now? Bahri, Priya Harrison-Woolrych, Mira Drug Saf Editorial Springer International Publishing 2012-12-13 2012 /pmc/articles/PMC3585946/ /pubmed/23061774 http://dx.doi.org/10.1007/BF03261984 Text en © Springer International Publishing AG 2012 |
| spellingShingle | Editorial Bahri, Priya Harrison-Woolrych, Mira Focusing on Risk Communication About Medicines: Why Now? |
| title | Focusing on Risk Communication About Medicines: Why Now? |
| title_full | Focusing on Risk Communication About Medicines: Why Now? |
| title_fullStr | Focusing on Risk Communication About Medicines: Why Now? |
| title_full_unstemmed | Focusing on Risk Communication About Medicines: Why Now? |
| title_short | Focusing on Risk Communication About Medicines: Why Now? |
| title_sort | focusing on risk communication about medicines: why now? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585946/ https://www.ncbi.nlm.nih.gov/pubmed/23061774 http://dx.doi.org/10.1007/BF03261984 |
| work_keys_str_mv | AT bahripriya focusingonriskcommunicationaboutmedicineswhynow AT harrisonwoolrychmira focusingonriskcommunicationaboutmedicineswhynow |